• Home
  • Stock
  • Gland Pharma Fundamental Analysis
  • Gland Pharma Fundamental Analysis

Gland Pharma fundamental analysis

GLAND

HealthcareLarge

1790.1

25.20 (-1.39%)
Last updated on 18 Nov, 2025 | 15:59 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Gland Pharma Fundamentals

P/E Ratio

37.82

P/B Ratio

3.13

Div. Yield

0.99

Sector P/E

37.93

Sector P/B

3.55

Sec. Div. Yield

0.56

  • Gland Pharma Fundamentals is currently trading with a P/E Ratio of 37.82, compared to the sector average of 37.93. Its P/B Ratio stands at 3.13, while the sector’s is 3.55. In terms of returns, the stock offers a Dividend Yield of 0.99%, which is than the sector’s 0.56%.

Gland Pharma Score Card

  • Price

    Attractive

  • Growth

    Average

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Gland Pharma reflects: Price – Attractive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.